Works matching AU Dornan, Mark H.

Results: 5
    1
    2
    3

    First-in-class small molecule potentiators of cancer virotherapy.

    Published in:
    Scientific Reports, 2016, p. 26786, doi. 10.1038/srep26786
    By:
    • Dornan, Mark H.;
    • Krishnan, Ramya;
    • Macklin, Andrew M.;
    • Selman, Mohammed;
    • El Sayes, Nader;
    • Son, Hwan Hee;
    • Davis, Colin;
    • Chen, Andrew;
    • Keillor, Kerkeslin;
    • Le, Penny J.;
    • Moi, Christina;
    • Ou, Paula;
    • Pardin, Christophe;
    • Canez, Carlos R.;
    • Le Boeuf, Fabrice;
    • Bell, John C.;
    • Smith, Jeffrey C.;
    • Diallo, Jean-Simon;
    • Boddy, Christopher N.
    Publication type:
    Article
    4

    Preclinical Development of PNT6555, a Boronic Acid–Based, Fibroblast Activation Protein-α (FAP)–Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 100, doi. 10.2967/jnumed.123.266345
    By:
    • Poplawski, Sarah E.;
    • Hallett, Robin M.;
    • Dornan, Mark H.;
    • Novakowski, Kyle E.;
    • Shuang Pan;
    • Belanger, Anthony P.;
    • Quang-De Nguyen;
    • Wengen Wu;
    • Felten, Albert E.;
    • Yuxin Liu;
    • Shin Hye Ahn;
    • Hergott, Valerie S.;
    • Jones, Barry;
    • Lai, Jack H.;
    • McCann, Joe A. B.;
    • Bachovchin, William W.
    Publication type:
    Article
    5